BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|December 22, 2020
- December 2020
- Volume 88
- Issue 12
Pet Peeves (December 2020)
Brought to you by The Sassy Pharmacist.
Advertisement
Brought to you by The Sassy Pharmacist.
OPTICAL ILLUSION
When the patient tells you they watched the doctor send the prescription.
FALSE PHONE CALL
When patients call the Doctor Line.
DRIVE-THROUGH DELIVERY
When they call to ask you to grab items to get at the drive-through window.
PUSHING MY BUTTONS
When they push the button at the drive through window and they just pulled up.
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We’ll share them in print and online.
Articles in this issue
almost 6 years ago
Pharmacists Play a Vital Role in Diabetes Managementalmost 6 years ago
Consider Impact of Certain Medications on Brain Functionalmost 6 years ago
Select High-Alert Medications Require Cautionalmost 6 years ago
Statins Are the Cornerstone of Lowering Cholesterol Levelsalmost 6 years ago
Acute Coronary Syndrome Is a Medical Emergencyalmost 6 years ago
Providers Have Duty to Warn About Patient Threatsalmost 6 years ago
Thrifty Mac Pharmacy Delights Patients and StaffAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
What the 2025-2030 Dietary Guidelines Mean for Heart Health
3
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
4
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
5